Skip to main content
OpenTrials

Clinical trial condition

Acrocephalosyndactylia

Explore clinical trials studying Acrocephalosyndactylia. Study availability and eligibility vary by location and protocol.

21 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Acrocephalosyndactylia trial results

Completed

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

NCT05253807

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +25 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Florida Cancer Specialists & Research Institute Fort Myers, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Memorial Healthcare System Pembroke Pines, Florida, United States
View all 36 locations
View Trial Details
Completed

A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma

NCT02699606

Conditions
Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +33 more
Locations
  • Beijing, China
  • Harbin, China
  • Nanjing, China
  • Seoul, South Korea
View Trial Details
Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma

NCT01703481

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +29 more
Locations
  • Birmingham, Alabama, United States
  • Tucson, Arizona, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
View all 37 locations
View Trial Details
Completed

Derazantinib and Atezolizumab in Patients With Urothelial Cancer

NCT04045613

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +26 more
Locations
  • CTCA Clinical Research Inc., Atlanta Newnan, Georgia, United States
  • Englander Institute Weill Cornell Medicine New York, United States
  • New York Cancer and Blood Specialists Port Jefferson Station, New York, United States
  • University of Texas Southwestern Medical Center (UTSWMC) Dallas, Texas, United States
View all 66 locations
View Trial Details
Completed

A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations

NCT03955913

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +12 more
Locations
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Medical Oncology Hematology Consultants, PA Newark, Delaware, United States
  • Affiliated Oncologists, LLC Chicago Ridge, Illinois, United States
View all 199 locations
View Trial Details
Completed

Phase 1b Trial of BGJ398/BYL719 in Solid Tumors

NCT01928459

Conditions
Acrocephalosyndactylia, Advanced Solid Tumors, Bone Diseases, +18 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa, Florida, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Karmanos Cancer Institute Dept of Onc Detroit, Michigan, United States
  • Washington University School of Medicine Onc Dept St Louis, Missouri, United States
View all 22 locations
View Trial Details

Related conditions